Upgrades
For Nike Inc (NYSE:NKE), Williams Trading upgraded the previous rating of Sell to Hold. Nike earned $0.94 in the first quarter, compared to $0.93 in the year-ago quarter. The stock has a 52-week-high of $131.31 and a 52-week-low of $82.24. At the end of the last trading period, Nike closed at $89.63.
Mizuho upgraded the previous rating for Spire Inc (NYSE:SR) from Neutral to Buy. In the third quarter, Spire showed an EPS of $0.42, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $75.83 and a 52-week-low of $55.34. At the end of the last trading period, Spire closed at $55.90.
For Ball Corp (NYSE:BALL), Jefferies upgraded the previous rating of Hold to Buy. For the second quarter, Ball had an EPS of $0.61, compared to year-ago quarter EPS of $0.82. The current stock performance of Ball shows a 52-week-high of $62.14 and a 52-week-low of $46.00. Moreover, at the end of the last trading period, the closing price was at $48.17.
BMO Capital upgraded the previous rating for Baytex Energy Corp (NYSE:BTE) from Market Perform to Outperform. In the second quarter, Baytex Energy showed an EPS of $0.27, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $4.43 and a 52-week-low of $2.89. At the end of the last trading period, Baytex Energy closed at $4.31.
See all analyst ratings upgrades.
Downgrades
Mizuho downgraded the previous rating for Sunoco LP (NYSE:SUN) from Buy to Neutral. For the second quarter, Sunoco had an EPS of $0.78, compared to year-ago quarter EPS of $1.20. The stock has a 52-week-high of $51.85 and a 52-week-low of $37.40. At the end of the last trading period, Sunoco closed at $51.22.
According to Northcoast Research, the prior rating for Badger Meter Inc (NYSE:BMI) was changed from Neutral to Sell. Badger Meter earned $0.76 in the second quarter, compared to $0.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $170.86 and a 52-week-low of $88.78. Badger Meter closed at $155.49 at the end of the last trading period.
Edward Jones downgraded the previous rating for Berkshire Hathaway Inc (NYSE:BRK) from Buy to Hold. For the second quarter, Berkshire Hathaway had an EPS of $6928.40, compared to year-ago quarter EPS of $6312.49.
See all analyst ratings downgrades.
Initiations
For Lantheus Holdings Inc (NASDAQ:LNTH), William Blair initiated coverage, by setting the current rating at Outperform. Lantheus Holdings earned $1.54 in the second quarter, compared to $0.89 in the year-ago quarter. The stock has a 52-week-high of $100.85 and a 52-week-low of $47.46. At the end of the last trading period, Lantheus Holdings closed at $69.53.
With a Buy rating, HSBC initiated coverage on Fortinet Inc (NASDAQ:FTNT). The price target seems to have been set at $75.00 for Fortinet. Fortinet earned $0.38 in the second quarter, compared to $0.24 in the year-ago quarter. The stock has a 52-week-high of $81.24 and a 52-week-low of $42.69. At the end of the last trading period, Fortinet closed at $58.60.
HSBC initiated coverage on Fair Isaac Corp (NYSE:FICO) with a Reduce rating. The price target for Fair Isaac is set to $729.00. Fair Isaac earned $5.66 in the third quarter, compared to $4.47 in the year-ago quarter. The stock has a 52-week-high of $916.41 and a 52-week-low of $391.84. At the end of the last trading period, Fair Isaac closed at $886.84.
With a Buy rating, HSBC initiated coverage on FedEx Corp (NYSE:FDX). The price target seems to have been set at $330.00 for FedEx. FedEx earned $4.55 in the first quarter, compared to $3.44 in the year-ago quarter. At the moment, the stock has a 52-week-high of $270.95 and a 52-week-low of $144.91. FedEx closed at $266.44 at the end of the last trading period.
See all analyst ratings initiations.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
According to Northcoast Research, the prior rating for Texas Roadhouse Inc (NASDAQ:TXRH) was changed from Neutral to Buy. For the second quarter, Texas Roadhouse had an EPS of $1.22, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $118.16 and a 52-week-low of $85.33. At the end of the last trading period, Texas Roadhouse closed at $95.57.
For Restaurant Brands International Inc (NYSE:QSR), Loop Capital upgraded the previous rating of Hold to Buy. Restaurant Brands Intl earned $0.85 in the second quarter, compared to $0.82 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.30 and a 52-week-low of $51.28. Restaurant Brands Intl closed at $66.73 at the end of the last trading period.
According to Loop Capital, the prior rating for Bumble Inc (NASDAQ:BMBL) was changed from Hold to Buy. For the second quarter, Bumble had an EPS of $0.05, compared to year-ago quarter EPS of $0.03. The current stock performance of Bumble shows a 52-week-high of $27.92 and a 52-week-low of $14.14. Moreover, at the end of the last trading period, the closing price was at $14.48.
According to Stifel, the prior rating for Brinker International Inc (NYSE:EAT) was changed from Hold to Buy. Brinker International earned $1.39 in the fourth quarter, compared to $1.15 in the year-ago quarter. The current stock performance of Brinker International shows a 52-week-high of $42.12 and a 52-week-low of $23.95. Moreover, at the end of the last trading period, the closing price was at $31.05.
Raymond James upgraded the previous rating for Trimble Inc (NASDAQ:TRMB) from Market Perform to Outperform. Trimble earned $0.64 in the second quarter, compared to $0.64 in the year-ago quarter. The current stock performance of Trimble shows a 52-week-high of $62.40 and a 52-week-low of $45.43. Moreover, at the end of the last trading period, the closing price was at $52.41.
According to Stifel, the prior rating for Editas Medicine Inc (NASDAQ:EDIT) was changed from Hold to Buy. For the second quarter, Editas Medicine had an EPS of $0.56, compared to year-ago quarter EPS of $0.78. The current stock performance of Editas Medicine shows a 52-week-high of $14.22 and a 52-week-low of $6.33. Moreover, at the end of the last trading period, the closing price was at $6.92.
According to Odeon Capital, the prior rating for M&T Bank Corp (NYSE:MTB) was changed from Buy to Hold. In the second quarter, M&T Bank showed an EPS of $5.12, compared to $3.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $192.30 and a 52-week-low of $109.36. M&T Bank closed at $126.46 at the end of the last trading period.
According to Mizuho, the prior rating for USA Compression Partners LP (NYSE:USAC) was changed from Neutral to Underperform. USA Compression Partners earned $0.11 in the second quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $26.40 and a 52-week-low of $16.39. At the end of the last trading period, USA Compression Partners closed at $25.41.
Wolfe Research downgraded the previous rating for ResMed Inc (NYSE:RMD) from Outperform to Peer Perform. In the fourth quarter, ResMed showed an EPS of $1.60, compared to $1.49 from the year-ago quarter. The current stock performance of ResMed shows a 52-week-high of $243.52 and a 52-week-low of $136.20. Moreover, at the end of the last trading period, the closing price was at $150.05.
With a Buy rating, Benchmark initiated coverage on Movado Group Inc (NYSE:MOV). The price target seems to have been set at $41.00 for Movado Group. Movado Group earned $0.38 in the second quarter, compared to $1.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $37.28 and a 52-week-low of $23.94. Movado Group closed at $25.97 at the end of the last trading period.
Raymond James initiated coverage on Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) with an Outperform rating. The price target for Alnylam Pharmaceuticals is set to $208.00. In the second quarter, Alnylam Pharmaceuticals showed an EPS of $1.62, compared to $2.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $242.74 and a 52-week-low of $168.65. Alnylam Pharmaceuticals closed at $174.03 at the end of the last trading period.
With an Outperform rating, Raymond James initiated coverage on AbbVie Inc (NYSE:ABBV). The price target seems to have been set at $177.00 for AbbVie. AbbVie earned $2.91 in the second quarter, compared to $3.37 in the year-ago quarter. The current stock performance of AbbVie shows a 52-week-high of $168.11 and a 52-week-low of $130.96. Moreover, at the end of the last trading period, the closing price was at $152.25.
With a Buy rating, Citigroup initiated coverage on Zions Bancorp NA (NASDAQ:ZION). The price target seems to have been set at $42.00 for Zions Bancorp. Zions Bancorp earned $1.11 in the second quarter, compared to $1.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.10 and a 52-week-low of $18.26. Zions Bancorp closed at $33.95 at the end of the last trading period.
Citigroup initiated coverage on Huntington Bancshares Inc (NASDAQ:HBAN) with a Buy rating. The price target for Huntington Bancshares is set to $12.00. In the second quarter, Huntington Bancshares showed an EPS of $0.35, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.74 and a 52-week-low of $9.13. Huntington Bancshares closed at $10.21 at the end of the last trading period.
With a Neutral rating, Citigroup initiated coverage on New York Community Bancorp Inc (NYSE:NYCB). The price target seems to have been set at $12.00 for New York Community. In the second quarter, New York Community showed an EPS of $0.47, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $14.22 and a 52-week-low of $5.81. At the end of the last trading period, New York Community closed at $11.28.
HC Wainwright & Co. initiated coverage on Elevation Oncology Inc (NASDAQ:ELEV) with a Buy rating. The price target for Elevation Oncology is set to $1.50. Elevation Oncology earned $0.37 in the second quarter, compared to $0.86 in the year-ago quarter. The stock has a 52-week-high of $5.89 and a 52-week-low of $0.64. At the end of the last trading period, Elevation Oncology closed at $0.68.
With a Neutral rating, Citigroup initiated coverage on First Citizens BancShares Inc (NASDAQ:FCNCA). The price target seems to have been set at $1520.00 for First Citizens BancShares. For the second quarter, First Citizens BancShares had an EPS of $52.60, compared to year-ago quarter EPS of $16.86. The current stock performance of First Citizens BancShares shows a 52-week-high of $1512.07 and a 52-week-low of $505.84. Moreover, at the end of the last trading period, the closing price was at $1370.60.
Wolfe Research initiated coverage on Petco Health and Wellness Co Inc (NASDAQ:WOOF) with a Peer Perform rating. Petco Health and Wellness earned $0.06 in the second quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Petco Health and Wellness shows a 52-week-high of $12.57 and a 52-week-low of $3.72. Moreover, at the end of the last trading period, the closing price was at $3.91.
With a Buy rating, UBS initiated coverage on Invitation Homes Inc (NYSE:INVH). The price target seems to have been set at $38.00 for Invitation Homes. For the second quarter, Invitation Homes had an EPS of $0.44, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $36.53 and a 52-week-low of $28.52. At the end of the last trading period, Invitation Homes closed at $31.76.
With a Neutral rating, UBS initiated coverage on American Homes 4 Rent (NYSE:AMH). The price target seems to have been set at $35.00 for American Homes 4 Rent. For the second quarter, American Homes 4 Rent had an EPS of $0.41, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $37.97 and a 52-week-low of $28.79. At the end of the last trading period, American Homes 4 Rent closed at $33.86.
With a Neutral rating, UBS initiated coverage on Opendoor Technologies Inc (NASDAQ:OPEN). The price target seems to have been set at $2.75 for Opendoor Technologies. For the second quarter, Opendoor Technologies had an EPS of $0.30, compared to year-ago quarter EPS of $0.20. The current stock performance of Opendoor Technologies shows a 52-week-high of $5.41 and a 52-week-low of $0.92. Moreover, at the end of the last trading period, the closing price was at $2.61.
With a Buy rating, HSBC initiated coverage on Synopsys Inc (NASDAQ:SNPS). The price target seems to have been set at $551.00 for Synopsys. Synopsys earned $2.88 in the third quarter, compared to $2.10 in the year-ago quarter. The current stock performance of Synopsys shows a 52-week-high of $471.15 and a 52-week-low of $267.00. Moreover, at the end of the last trading period, the closing price was at $460.71.
HSBC initiated coverage on Palo Alto Networks Inc (NASDAQ:PANW) with a Hold rating. The price target for Palo Alto Networks is set to $242.00. In the fourth quarter, Palo Alto Networks showed an EPS of $1.44, compared to $0.80 from the year-ago quarter. The current stock performance of Palo Alto Networks shows a 52-week-high of $258.88 and a 52-week-low of $132.22. Moreover, at the end of the last trading period, the closing price was at $235.18.
With a Hold rating, HSBC initiated coverage on Intuit Inc (NASDAQ:INTU). The price target seems to have been set at $520.00 for Intuit. In the fourth quarter, Intuit showed an EPS of $1.65, compared to $1.10 from the year-ago quarter. The current stock performance of Intuit shows a 52-week-high of $558.64 and a 52-week-low of $352.66. Moreover, at the end of the last trading period, the closing price was at $512.24.
HSBC initiated coverage on Autodesk Inc (NASDAQ:ADSK) with a Hold rating. The price target for Autodesk is set to $214.00. Autodesk earned $1.91 in the second quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Autodesk shows a 52-week-high of $233.53 and a 52-week-low of $179.61. Moreover, at the end of the last trading period, the closing price was at $207.89.
HSBC initiated coverage on Akamai Technologies Inc (NASDAQ:AKAM) with a Hold rating. The price target for Akamai Techs is set to $106.00. In the second quarter, Akamai Techs showed an EPS of $1.49, compared to $1.35 from the year-ago quarter. The stock has a 52-week-high of $109.05 and a 52-week-low of $70.65. At the end of the last trading period, Akamai Techs closed at $107.04.
With a Hold rating, HSBC initiated coverage on Adobe Inc (NASDAQ:ADBE). The price target seems to have been set at $519.00 for Adobe. In the third quarter, Adobe showed an EPS of $4.09, compared to $3.40 from the year-ago quarter. The current stock performance of Adobe shows a 52-week-high of $570.24 and a 52-week-low of $274.88. Moreover, at the end of the last trading period, the closing price was at $504.67.
HSBC initiated coverage on United Parcel Service Inc (NYSE:UPS) with a Hold rating. The price target for United Parcel Service is set to $170.00. United Parcel Service earned $2.54 in the second quarter, compared to $3.29 in the year-ago quarter. The stock has a 52-week-high of $197.80 and a 52-week-low of $150.54. At the end of the last trading period, United Parcel Service closed at $155.50.
With a Strong Buy rating, Raymond James initiated coverage on Customers Bancorp Inc (NYSE:CUBI). The price target seems to have been set at $60.00 for Customers Bancorp. For the second quarter, Customers Bancorp had an EPS of $1.65, compared to year-ago quarter EPS of $1.77. At the moment, the stock has a 52-week-high of $45.00 and a 52-week-low of $6.87. Customers Bancorp closed at $32.35 at the end of the last trading period.
For Jazz Pharmaceuticals PLC (NASDAQ:JAZZ), Raymond James initiated coverage, by setting the current rating at Market Perform. In the second quarter, Jazz Pharmaceuticals showed an EPS of $4.51, compared to $4.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $160.96 and a 52-week-low of $120.64. Jazz Pharmaceuticals closed at $131.03 at the end of the last trading period.
Raymond James initiated coverage on Ionis Pharmaceuticals Inc (NASDAQ:IONS) with a Strong Buy rating. The price target for Ionis Pharmaceuticals is set to $63.00. Ionis Pharmaceuticals earned $0.41 in the second quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $47.74 and a 52-week-low of $32.69. At the end of the last trading period, Ionis Pharmaceuticals closed at $46.26.
DA Davidson initiated coverage on NICE Ltd (NASDAQ:NICE) with a Neutral rating. The price target for NICE is set to $190.00. For the second quarter, NICE had an EPS of $2.13, compared to year-ago quarter EPS of $1.86. At the moment, the stock has a 52-week-high of $231.54 and a 52-week-low of $164.86. NICE closed at $167.80 at the end of the last trading period.
With an Outperform rating, Oppenheimer initiated coverage on Ingredion Inc (NYSE:INGR). The price target seems to have been set at $120.00 for Ingredion. In the second quarter, Ingredion showed an EPS of $2.32, compared to $2.12 from the year-ago quarter. The current stock performance of Ingredion shows a 52-week-high of $113.46 and a 52-week-low of $79.75. Moreover, at the end of the last trading period, the closing price was at $97.57.
Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ:FUSN) with an Outperform rating. The price target for Fusion Pharmaceuticals is set to $13.00. In the second quarter, Fusion Pharmaceuticals showed an EPS of $0.38, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of $5.63 and a 52-week-low of $1.98. At the end of the last trading period, Fusion Pharmaceuticals closed at $2.64.
